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Background: Role of cytochrome c (Cyt c) is an apoptogenic agent under certain conditions. The mitochondrial 
permeability transition pore (MPTP) plays an important role in cell death since it opens, leading to mitochondrial 
swelling and release of Cyt c, which initiates apoptosis. By inhibiting the opening of MPTP, cyclosporine A (CSA) may 
contribute to maintaining mitochondrial homeostasis. We investigate the effects of the partial sciatic nerve injury 
(PSNI)-induced neuropathic pain model on mitochondrial Cyt c release and the effects of CSA on neuroprotection 
by mitochondrial stabilizing activity in PSNI rats.
Methods: Rats were assigned to two groups that received different operations (Group P; PSNI operation, Group S; 
sham operation). The changes of cyt c and GABAergic neuron were evaluated in the spinal cord tissue. After which, 
PSNI rats randomly received CSA (Group C) or saline (Group S), and the changes of mechanical thresholds with Cyt c 
and GABAergic neuron were checked.
Results: PSNI in rats increased the release of cytosolic Cyt c. However, GABAergic cells were not decreased in the 
spinal cord level on the ipsilateral side to the PSNI. The second experiment reveal a reduction in Cyt c release, using 
CSA in PSNI model. Rats receiving CSA were afforded the antiallodynia without decrease of GABAergic cell. 
Conclusions: The Cyt c probably contributes to nerve dysfunction after PSNI. PSNI induced neuropathic pain was 
profoundly linked to mitochondrial stabilization. Thus, the potent neuroprotector, CSA, might produce antiallodynia 
through its capability to inhibit the opening of MPTP. (Korean J Anesthesiol 2012; 62: 365-370)
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Introduction
Cytochrome c (Cyt c) is a ubiquitous, heme-containing pro-
tein that normally resides in the space between the inner and 
outer mitochondrial membranes. The classical function of Cyt 
c in the intermembrane space is as a component of the electron 
transport chain and leading to the reduction of oxygen to water. 
In 1996, another role for Cyt c as an apoptogenic agent was 
reported [1]. The significance of Cyt c to the apoptotic process 
was revealed by the findings that mitochondrial released Cyt 
c combines with apoptosis protease activating factor-1 (Apaf-
1), procaspase-9, and dATP in the cytosol. Thereby, producing 
active caspase-9 [2,3]. As apoptosis has been implicated in a 
number of CNS disorders, including neurodegenerative diseases 
and damages as a consequence of stroke or CNS trauma, 
pharmacological prevention of Cyt c release from mitochondria 
is being intensely investigated as an approach with potential to 
reduce significantly the clinical manifestations of apoptosis in 
the CNS.
Neuropathic pain results from pathology in the nervous 
system. By modulating both synaptic inflow and dorsal horn 
neuronal excitability, presynaptic and postsynaptic inhibition 
regulates the transfer of information from the periphery to the 
CNS. In neuropathic pain, noxious stimulation sensitizes central 
neurons involved in processing of nociceptive information and 
this sensitization induces nocuous responsiveness to innocuous 
peripheral stimulation. This phenomenon is called ‘‘central 
sensitization’’ . Reduction or elimination of spinal cord inhibition 
could be expected and sensitization of higher order neurons is a 
key mechanism involved in generating pathological excitability, 
that is to say the development of neuropathic pain.
Partial sciatic nerve injury (PSNI) [4] is a well-characterized 
mononeuropathy model to study neuropathic pain caused 
by nerve injury. Interest has been recently focused on the 
intracellular transduction pathway, involved in the trans-
synaptic effects of nerve injury, especially in the GABAergic 
inhibitory interneuron. In the present study, focuses were on 
some of the pieces of evidence from results that support a role 
for mitochondrial Cyt c release in acute neurological injury and 
chronic neurodegeneration. The authors investigate the effects 
of the PSNI-induced neuropathic pain model in mitochondrial 
Cyt c release and the effects of cyclosporine A (CSA) that has 
neuroprotection on its mitochondria stabilizing activity in PSNI.
Materials and Methods
Male Sprague-Dawley rats weighing 180-200 g were used. 
Rats were housed with free access to food and water under a 
natural day/night cycle. Rats were acclimated for 7 days before 
any experimental procedures. All experiments were conducted 
during the lights-on period in a quiet room. Animal care was 
provided in adherence to guidelines of the Institutional Care 
and Use Committee at Pusan National University Hospital.
Two sets of experiments were performed. Firstly, the animals 
(total n = 30) were randomly assigned to one of the 2 groups and 
each group received different operations (Group P; rats received 
PSNI operation, Group S; rats received sham operation, n = 15 
per group). PSNI model was performed as described previously 
by Seltzer et al. [4]. Briefly, the rats were anesthetized with 
3 vol% sevoflurane and 97% oxygen and placed in a prone 
position. An incision was made into the left thigh. After the thigh 
muscle was pushed aside under the dissection microscope, 
the sciatic nerve bundle was exposed, and then tightly ligated 
a half of nerve with 6-0 silk thread. The wounds were closed. 
Sham-operated control rats underwent an identical surgical 
procedure as the PSNI rats, except that the sciatic nerve bundle 
was without ligation.
For western blot and immunohistochemical staining, 
five rats in each groups were deeply anesthetized and killed 
at 1, 3, and 7 days after the operation. The spinal cords that 
included L4-5 were removed and immediately frozen on dry 
ice. Spinal cord tissue was homogenized in buffer (250 mM 
sucrose, 20 mM Tris-HCL [pH 7.4], 1.5 mM Na-EDTA, 1.5 mM 
Na-EGTA, 1 mM MgCl2, 1 mM DTT [Sigma-Aldrich, St. Louis, 
USA], 20 mM KCl [Samchun Pure Chemical, Pyeongtaek, 
Korea]) and centrifuged. The supernatant was decanted and 
used for western blot analyses. The protein concentration of 
the supernatant was measured using a BCA protein assay kit 
(Pierce, Rockford, USA). The supernatant, with equal amounts 
of 50 μg protein, was then fractionated by sodium dodecyl 
sulfate-polyacryl amide gel electrophoresis (SDS-PAGE) gel and 
transferred onto a nitrocellulose membrane (Millipore, Bedford, 
USA). Membrane were blocked with 2% BSA in Tris-buffered 
saline containing 0.1% Tween (TBST) at room temperature 
for 1 h and then incubated overnight at 4
oC with antibody 
against β-actin and Cyt c. After washing with TBST, anti-rabbit 
IgG and anti-mouse IgG2B was used as a secondary antibody 
(1 : 2,000 dilution in 2% BSA in TBST, 1 h 30 min incubation) 
and the antigen antibody complexes were visualized using an 
enhanced chemiluminescence detection reagent (Amersham). 
Bands were scanned using a densitometer (GS-700; Bio-Rad 
Laboratories), and quantification was performed using Multi-
Analyst 1.0.2 software (blue color).
The spinal cords (L4-5) were sectioned transversely at a 
thickness of 6 μm on a freezing microtome for immunohisto-
chemical staining. One tissue from each rats were then 
dehydrated for 2 h and fixed for 15 min in cold acetone. 
After washed by PBS and non-specific antibody binding was 
inhibited by incubation for 1 hour in blocking solution (1% 
BSA, 0.2% powdered skim milk, 0.3% Triton-X 100 in PBS). 367 www.ekja.org
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Primary antibodies were diluted in PBS blocking buffer and 
slides were incubated overnight at 4
oC in primary antibodies 
to GABAergic cells antibody (abCam, Share, UK). After washed 
by PBS, secondary antibodies Alexa Fluor 633 anti-rabbit IgG 
(Invitrogen, Oregon, USA; blue color) were used to locate the 
GABAergic cells in each section. The nuclei were visualized 
using Leica TCS SP2 (Leica Microsystems Heidelberg GmbH, 
Germany). For fluorescence intensity analysis, LCS light 
software (Leica Microsystems Heidelberg GmbH, Germany) 
was used. The staining was visualized using an optical 
microscope, the appearance of GABAergic cells was assessed at 
X1600 and fluorescence intensity was assessed at X400.
In a second set of experiments, the animals (total n = 40) 
were randomly assigned to one of 2 treatment groups. Depen-
ding upon group designation, the animals received CSA (Group 
C, n = 20) or saline (Group S, n = 20) at pre-operation, post-
operative 1 day, 3 day and 7 day. CSA injected intraperitoneally 
in a solution of polyethylene glycol/sterile saline/cremophor oil 
solution (20 mg/kg). The rats of group S were treated with the 1 
ml of saline in order to serve as controls.
Behavioral tests were conducted blindly by the experimenter 
who did not know the nature of the experimental manipulation 
and performed on 5 rats per group at preoperation, post-
operative day 1, day 3 and day 7. The foot withdrawal threshold 
to mechanical stimuli (mechanical threshold) was used as an 
indicator of mechanical sensitivity of the affected paw. Before 
drugs injected to rats, behavioral tests were performed. The foot 
withdrawal threshold to mechanical stimuli was assessed by 8 
calibrated von Frey hairs. For each test, the animal was placed 
in a plastic chamber (15 × 20 × 30 cm) and habituated for at 
least 15 min. The chamber was placed on top of a mesh screen 
so that mechanical stimuli could be administered to the plantar 
surface of left hind paw. Thresholds were determined by the 
up-down method [5], using a set of von Frey monofilaments. 
Eight von Frey filaments with bending forces of approximately 
equal logarithmic increments (0.22) were chosen (equivalent to 
0.41, 0.70, 1.20, 2.00, 3.63, 5.50, 8.50, and 15.10 g, respectively). 
Starting with the 2.0 g hair, the filaments were applied 
perpendicular to the ventral surface of the base at the proximal 
part of the third or fourth toe for 6 s. An abrupt withdrawal 
of the foot during stimulation or immediately after stimulus 
removal was counted as a positive response. Whenever a 
positive response occurred, the next smaller von Frey filament 
was applied. Whenever a negative response occurred, the next 
higher filament was applied. The test was continued until the 
third change in response to stimuli had been obtained. The 50% 
threshold value was calculated using Dixon’s formula [6].
Cyt c and GABAergic neuron were evaluated by the western 
blot method and immunohistochemical staining as described 
in first experiment (n = 15 per group).
All data are presented as means ± standard errors of the 
mean (SEM) and analyzed using the PASW 18K statistical 
program (SPSS institute, USA). Mechanical thresholds, Cyt c 
and fluorescence intensities of sections were analyzed with the 
Mann-Whitney U test to compare values between groups at 
each time point. In all cases, a P value < 0.05 was considered to 
be significant.
Results
In the first experiment, postoperative foot drop was not 
observed. In group P, the nerve damage associated with PSNI 
elicited behavioral features characteristic of neuropathic 
pain: the rats developed abnormal gait, posture, guarding and 
protecting behavior and licking of the hind paw of the ipsilateral 
side of sciatic ligation after 1 day of operation. The rats did not 
put weight on the affected side and the hind leg of the affected 
side was drawn close to the body with distinctive guarding 
posture. The foot was ventroflexed and the toes were held 
together tightly. PSNI of the sciatic nerve in the rat produced 
a profound and prolonged decrease of mechanical thresholds 
within 1 day of the nerve injury. As shown in Fig. 1, Cyt c of 
group P was increased compared with group S (P = 0.020, 0.021 
and 0.021) in the L4-5 at 1, 3 and 7 days after PSNI operation. 
The number of neurons in the ipsilateral L4-5 dorsal horn 
(laminae I-III) was not reduced between all groups at 1, 3, and 
7 days after operation (X1600). To confirm the reliability and 
specificity of the neuronal marker, fluorescence intensities of 
these sections were examined by electron microscope (X400) 
and the median of group P was not significantly different from 
Fig. 1. Effects of partial sciatic nerve injury (PSNI) on cytochrome c 
(Cyt c) in rats. Cyt c of group P was increased compared with group 
S (P = 0.020, 0.021 and 0.021) in the L4-5 at postoperation 1, 3 and 
7 days. PSNI leads to increasing of Cyt c in rats. *P < 0.05 when 
compared with that of group S. S: sham operation group, P: PSNI 
operation group, Day1: 1 day after operation, Day3: 3 days after 
operation, Day7: 7 days after operation.368 www.ekja.org
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group S at 1, 3, and 7 days after operation (Fig. 2).
In the second experiment, the mechanical thresholds of 
group C were high compared with that of group S after 7 days 
(P = 0.009) and significant anti-allodynic effect occurred on 
the 7th day after PSNI surgery (Fig. 3). The Cyt c level of group 
S was significantly greater than that of group C at 7th day after 
PSNI surgery (P = 0.021). A significant reduction of Cyt c by CSA 
was shown after PSNI operation (Fig. 4). But same as the first 
experiment, there was no significant difference between group 
S and group C in GABAergic neuron cells and fluorescence 
intensities at 7 days after PSNI (Fig. 5).
Discussion
In the present study, we demonstrated that PSNI in rats 
increased the release of cytosolic Cyt c from mitochondria. 
However, GABAergic cells were not decreased in the spinal cord 
level on the ipsilateral side to the PSNI. The results of second 
experiment reveal a dramatic reduction in Cyt c release using 
CSA in PSNI model. Rats receiving CSA were afforded the 
antiallodynia without decrease of GABAergic cell.
A great advance in our understanding of the mechanisms 
that underlie neuropathic pain states has come from the 
development of animal models. Since most of these models 
involve partial nerve injury, some input is preserved. This allows 
behavioral analysis of changes in thermal and mechanical 
withdrawal thresholds, in addition to the assessment of spon-
taneous pain and autotomy. PSNI model not only produces 
profound behavioral indicators of persistent pain, but it 
Fig. 2. Effects of partial sciatic nerve injury (PSNI) on GABAergic 
neuron in rats. The fluorescence intensities of group P were not 
significantly different from group S in the ipsilateral L4-5 dorsal horn 
(laminas I-III) at 1, 3, and 7 days after operation. The GABAergic 
neuron in the ipsilateral L4-5 dorsal horn (laminas I-III) was not 
reduced by PSNI at 1, 3, and 7 days after operation. S: sham operation 
group, P: PSNI operation group, Day1: 1 day after operation, Day3: 3 
days after operation, Day7: 7 days after operation.
Fig. 3. The effects of cyclosporine A (CSA) on mechanical thresholds 
in partial sciatic nerve injury (PSNI) in rats. The mechanical 
thresholds of group C were high compared with that of group S after 7 
days (P = 0.009) and significant anti-allodynic effect occurred by CSA 
on the 7th day after PSNI surgery. S: saline intraperitoneal injection 
group, C: CSA intraperitoneal injection group, Preop: preoperation, 
Day7: 7 days after operation. *P < 0.05 when compared with that of 
group S. 
Fig. 4. The effects of cyclosporine A (CSA) on mitochondrial 
cytochrome c (Cyt c) release in partial sciatic nerve injury (PSNI) in 
rats. (A) A reduction of Cyt c by CSA was shown after 7 days on PSNI 
rats. (B) The Cyt c level of group S was significantly greater than that 
of group C at 7th day after PSNI surgery (P = 0.021). *P < 0.05 when 
compared with that of group S. S: saline intraperitoneal injection 
group, C: CSA intraperitoneal injection group, Day7: 7 days after 
operation.369 www.ekja.org
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also initiates a cascade of events resulting in altered peptide 
expression in the superficial dorsal horn [7]. Although the 
relationship of these changes is unclear, it has been suggested 
that alterations in peptide expression represent adaptive 
responses to promote survival and recovery of the injured 
neurons [8]. In the present study, there were a significant 
difference in the level of Cyt c between sham and PSNI model 
in the L4-5 segment, and moreover the effects of CSA which 
decreased Cyt c released from mitochondria compared with 
S group. These results suggest that PSNI-induced mechanical 
allodynia is associated more with release Cyt c from 
mitochondria.
Recognition that mitochondria could release triggers 
of cell death, and that at least one of these triggers, Cyt c, 
was sufficient for the latter stages of cell death, highlighted 
the potential gatekeeper role of mitochondria in cell death 
cascades [9]. The link between mitochondrial function and 
the transduction of cell death signals presumably involves 
interactions between mitochondrial free radical production 
and Ca
2+ homeostasis [10,11]. This dysfunction appears to be 
dependent upon the sequestration of Ca
2+ by mitochondria, 
given the fact that inhibition of mitochondrial Ca
2+ uptake is 
neuroprotective. By inhibiting the opening of the mitochondrial 
permeability transition pore (MPTP), via its interaction with 
matrix cyclophilin, CSA maintains mitochondrial homeostasis. 
The modulation of the MPTP, a non-specific pore of the inner 
mitochondrial membrane, by CSA is well documented and has 
been shown to decrease in efficacy as a function of time [12-
14]. In the central nervous system, mitochondrial involvement 
seems essential for normal expression of cell death phenotypes, 
and interference with these pathways thus seems a reasonable 
approach to neuroprotection. The MPTP plays an important 
role in cell death since it opens, leading to mitochondrial 
swelling and release of Cyt c, which initiates apoptosis. In first 
experiment, significant increase the ratio of Cyt c in P group 
after PNSI operation was showed and second experiment 
showed CSA attenuated the decrease of mechanical threshold 
and the increase the ratio of Cyt c. These findings suggest that 
the release of Cyt c from mitochondria was a result from PSNI 
and CSA decreased release of Cyt c of upper neuronal cell.
Although MPTP inhibitors are suggested to be protective 
in some models [15], inhibition of Cyt c release was not 
demonstrated in most cases and non-MPTP effects were not 
excluded, such as protective general inhibition of protein 
synthesis [16]. Detailed analysis using both biochemical and 
imaging techniques have excluded a role for the MPTP in 
the mechanism of Bax-induced Cyt c release from isolated 
brain mitochondria [11,17]. Nevertheless, the MPTP may still 
play a role in neuronal cell death, perhaps by signaling Bax 
translocation to mitochondria [18], participating in intracellular 
Ca
2+ or ROS signaling, or regulating the release of larger 
mitochondrial apoptogenic proteins that occurs downstream 
of Cyt c release. Recently it was shown that both Bax and Bak 
are dispensable for NMDA-induced death of cerebellar granule 
neurons [19], perhaps suggesting a comparatively greater role 
for calcium in forms of neuronal death that are not purely 
apoptotic.
The use of CSA is associated with numerous side effects. 
Neurotoxicity was previously less well-known, but with gro-
wing experiences, central nervous system side effects are 
now reported. The rate of neurotoxicity appears to be dose 
related and increases with additional doses of chemotherapy 
delivered [13]. Unfortunately, neurotoxicity due to CSA can 
occur at normal dose and at high dose of drug. In contrast, CSA 
greatly induces the release of these neurotransmitters at low 
concentrations [20] and have neuroprotective effects.
A permanent decrease or loss of spinal inhibition after 
nerve injury is a potential mechanism of neuropathic pain. 
Fig. 5. The effects of cyclosporine A (CSA) on GABAergic cell in 
partial sciatic nerve injury (PSNI) in rats. (A) The GABAergic neuron 
in the ipsilateral L4-5 dorsal horn (laminas I-III) was not reduced 
by PSNI at 7 days after operation (X1600). (B) The fluorescence 
intensities of group C were not significantly different from group 
S in the ipsilateral L4-5 dorsal horn (laminas I-III) at 7 days after 
PSNI operation. S: saline intraperitoneal injection group, C: CSA 
intraperitoneal injection group, Day7: 7 days after operation.370 www.ekja.org
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This mechanism that has been proposed to contribute to 
neuropathic pain is peripheral nerve injury-induced loss of the 
GABAergic inhibitory interneuronal system in the spinal cord 
[21]. The GABAergic inhibitory interneuronal system has an 
important role in the modulation of the noxious stimulation 
transmitted from the primary afferent input. Some studies 
revealed the role of GABAergic inhibitory interneuronal system 
in the modulation of the pain transmission and the apoptotic 
changes of the GABAergic interneurons in the neuropathic pain 
[7]. On the contrary to this, there is also evidence to suggest that 
death of GABAergic neurons does not occur after nerve injury. 
Polgar et al. [22] showed that there was no loss of neurons and 
no change in the proportion that were GABA-immunoreactive, 
in laminae I-III of the ipsilateral dorsal horn in CCI model. 
They also found those 4 weeks after spared nerve injury (SNI) 
the number of neurons in laminae I-III was not altered 
and that the apoptotic cells seen in the spinal cord at earlier 
stages were microglia, rather than neurons. However, even if 
GABAergic neurons do not undergo apoptosis, loss of inhibition 
after nerve injury could still result from depletion of GABA from 
their axon terminals, leading to reduction of transmitter release, 
and thus the size of inhibitory postsynaptic currents [23].
In conclusion, the present study suggests that mitochondrial 
release of Cyt c probably contributes to nerve dysfunction 
after PSNI. This study provides evidence that PSNI induced 
neuropathic pain was profoundly linked to mitochondrial 
stabilization, but it is presumed that pathology of PSNI is not 
related to the loss of neurons in dorsal horn lamina in the 
rats. Thus, in agreement with previous evidence, the potent 
neuroprotector, CSA, might produce antiallodynia through its 
capability to inhibit the opening of MPTP.
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